Ferrous sulfate 3 days week — Competitive Intelligence Brief

Ferrous sulfate 3 days week (Ferrous sulfate 3 days week) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Iron supplement. Area: Anemia.

phase 2 Iron supplement Anemia Small molecule

Target snapshot

Ferrous sulfate 3 days week (Ferrous sulfate 3 days week) — Universidade Federal Fluminense. Ferrous sulfate works by replacing iron in the body.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Ferrous sulfate 3 days week TARGET	Ferrous sulfate 3 days week	Universidade Federal Fluminense	phase 2	Iron supplement
Iron therapy	Iron therapy	GlaxoSmithKline	marketed	Iron supplement
ARM B: IV iron + epoietin zeta sequence	ARM B: IV iron + epoietin zeta sequence	Centre Francois Baclesse	marketed	Iron supplement + Erythropoiesis-stimulating agent (ESA)	Erythropoietin receptor (EPOR); iron as cofactor for hemoglobin synthesis
Iron protein succinylate oral solution	Iron protein succinylate oral solution	Lee's Pharmaceutical Limited	marketed	Iron supplement
elemental iron (NovaFerrum®)	elemental iron (NovaFerrum®)	University of Texas Southwestern Medical Center	marketed	Iron supplement	Iron (Fe2+/Fe3+) — cofactor for hemoglobin and myoglobin synthesis
Iron supplement C	Iron supplement C	Tanabe Pharma Corporation	marketed	Iron supplement	Iron (Fe2+/Fe3+)
ionic iron	ionic iron	Milton S. Hershey Medical Center	marketed	Iron supplement

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Iron supplement class)

1. Tanabe Pharma Corporation · 4 drugs in this class
2. Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri · 2 drugs in this class
3. Universidade Federal Fluminense · 2 drugs in this class
4. Clinica Fabia Mater · 1 drug in this class
5. GlaxoSmithKline · 1 drug in this class
6. Hatem AbuHashim · 1 drug in this class
7. Hospital Universitari Vall d'Hebron Research Institute · 1 drug in this class
8. Laboratoire Innotech International · 1 drug in this class
9. Lee's Pharmaceutical Limited · 1 drug in this class
10. Milton S. Hershey Medical Center · 1 drug in this class